Here's something to read:
Companies Like Cynata Therapeutics (ASX:CYP) Could Be Quite Risky (yahoo.com)Now they are probably trolls as well but before you shyte can them (along with anything else that differs to the lyrics in the Cynata Hymn book), realise that these people agree with the CYP BoDs and yourself:
"SOLID" cash runway!
It really is SOLID!!
But......
And that's where I question the use of "SOLID".
I don't think Cynata is going to reduce cash burn "drastically" because costs relating to the recent candidate enrolments for the FDA GVHD P2 trial has started and with the rest of the candidates to be enrolled by the end of 2024, I think that costs are going to increase significantly.
And as such, reducing the runway.
Now, I know that I am in the minority with my radical thinking AND Cynata management have many, many, many times stated that they have enough cash to complete the trial by the end of 2025, but.........well........I question it?
I must not understand something. Can you explain it to me?
Oh yeah, and y a h o o are quoting your mates and its a few weeks old:
(20min delay)